WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors appointed a slate of nominees to the PCORI Methodology Committee at its March meeting. The appointees include committee members who will serve two-year terms and members who will serve four-year terms.

The PCORI Methodology Committee’s roles include developing high-quality methodological standards to guide the conduct of patient-centered comparative clinical effectiveness research (CER), establishing priorities to address gaps in research methods or their applications, and facilitating the use of standards and cutting-edge methods in patient-centered CER.

“We are grateful for the robust interest from a wide range of members of the scientific community in serving on the PCORI Methodology Committee,” said PCORI Executive Director Nakela L. Cook, M.D., MPH. “An important aim of health research is to conduct studies that provide accurate estimates of benefit or harm and to do so for diverse populations. Our Methodology Committee is vital to ensuring rigor in the methods used by the research teams PCORI funds and that their research is centered on what matters most to patients and all health decision makers.”

Members Appointed to Two-Year Terms (April 1, 2023–June 30, 2025):

• Naomi Aronson, Ph.D.
• Cynthia Girman, DrPH, FISPE
• Steven Goodman, M.D., Ph.D., MHS
• Mark Helfand, M.D., M.S., MPH
• Sally Morton, Ph.D.
• Robin Newhouse, Ph.D., RN
• Adam Wilcox, Ph.D.

Members Appointed to Four-Year Terms (April 1, 2023–June 30, 2027):

• Suzanne Bakken, Ph.D., RN
• Cathy Bradley, Ph.D., MPA
• Matthew Fox, DSc, MPH
• Jeremy Goldhaber-Fiebert, Ph.D.
• Larry Hearld, Ph.D., MSA, MBA
• Lehana Thabane, Ph.D., MSc
• Shirley Wang, Ph.D., ScM
• Susan Zickmund, Ph.D.

Brief biographies including details on the members’ affiliations, expertise and conflict of interest disclosures can be found on PCORI’s website. In addition to the 15 members appointed by the Board, the director of the Agency for Healthcare Research and Quality and the director of the National Institutes of Health, or their designees, also serve on the committee.

“This group of individuals who bring a range of disciplines and diverse areas of scientific expertise and contributions is invaluable to PCORI’s work to establish and update methodological standards and guidance for comparative clinical effectiveness research,” said Harv Feldman, M.D., MSCE, PCORI’s Deputy Executive Director for Patient-Centered Research Programs. “Following a careful selection process, we are delighted to have a distinguished and broad-reaching cadre of members joining the committee.”

Cook also acknowledged the Methodology Committee members who have completed their terms of service. “We greatly appreciate the service of Methodology Committee members who have contributed their expertise and insights over the past several years,” Cook said. “It has been our privilege to have their involvement with PCORI in this important capacity.”